Screener
Whitehawk Therapeutics WHWK Invested capital
Discontinued — last reported Q4 '24
Invested capital at other companies
Other financials
Where this comes from
Calculated from Whitehawk Therapeutics’s reported figures.
The source filing: Whitehawk Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:25 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212075
FAQ
- What is Whitehawk Therapeutics's invested capital?
- Whitehawk Therapeutics (WHWK) reported invested capital of $24.64M in Q4 2024.
- How has Whitehawk Therapeutics's invested capital changed year-over-year?
- Whitehawk Therapeutics's invested capital decreased by 43.5% year-over-year, from $43.57M to $24.64M.
- What is the long-term trend for Whitehawk Therapeutics's invested capital?
- Over 3 years (2021 to 2024), Whitehawk Therapeutics's invested capital has grown at a 27.2% compound annual growth rate (CAGR), from -$11.98M to $24.64M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Whitehawk Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude